Subconjunctival Bevacizumab Injection for Corneal Neovascularization in Recurrent Pterygium
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Current Eye Research
- Vol. 33 (1) , 23-28
Abstract
Purpose: We report on the use of subconjunctival bevacizumab on corneal vessel density in recurrent pterygia.Methods: The charts of 5 patients with recurrent pterygium, who received subconjunctival injections of bevacizumab (2.5 mg/0.1 ml) were retrospectively reviewed. Ophthalmic evaluation included Snellen visual acuity (VA), tonometry and complete examination before the injection and at 1 week and 1 and 3 months thereafter. Digital photographs of the eyes were analyzed by image analysis software to determine the area of cornea covered by new vessels as a percentage of the total corneal area. Results: No ocular or systemic adverse events were observed. No change in visual acuity was noted in any patient following the injection. The mean change in corneal vascularization after one bevacizumab injection was 0.03% ± 0.45, while after two injections the change was 0.025% ± 0.19 (both not statistically different than zero, t-test). Conclusions: Short-term results suggest that subconjunctival bevacizumab is well tolerated but does not cause regression of corneal vessels in recurrent pterygium.Keywords
This publication has 23 references indexed in Scilit:
- Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)British Journal of Ophthalmology, 2006
- Endothelial progenitor cells in pterygium pathogenesisEye, 2006
- Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical StudyOphthalmology, 2005
- Maximum Tolerated Dose of a Humanized Anti–Vascular Endothelial Growth Factor Antibody Fragment for Treating Neovascular Age-Related Macular DegenerationOphthalmology, 2005
- Bevacizumab suppresses choroidal neovascularisation caused by pathological myopiaBritish Journal of Ophthalmology, 2005
- The pathogenesis of pterygiaCurrent Opinion in Ophthalmology, 1999
- Immunolocalization of bFGF in PterygiaCornea, 1997
- Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-β and tumor necrosis factor-α in the pterygiumActa Histochemica, 1996
- Pathogenesis of pterygiumEye, 1989
- Histology of pterygium: an electron microscopic study.British Journal of Ophthalmology, 1983